Assessment of Health Related Quality of Life and Adr India Betic Foot Patient Sunder Going Ceftriaxone Andpiperacillin/tazobactam Treatment in Tertiary Care Hospital
Main Article Content
Abstract
To conduct a comparative study based on HRQoL in diabetic foot patients treated with Ceftriaxone and with Piperacillin/Tazobactam, to identify ADRs associated with these antibiotics
References
Das A., Pendsey S., Abhyankar M., Malabade R. Management of diabetic foot in an Indian clinical setup: An opinion survey. Cureus [Internet]. 2020 [cited 2023 Oct 6];12(6).
Available from: http://dx.doi.org/10.7759/cureus.8636
Oliver T.I., Mutluoglu M. Diabetic Foot Ulcer. StatPearls Publishing; 2022.
Hurlow J.J., Humphreys G.J., Bowling F.L., McBain A.J. Diabetic foot infection: A critical complication. International Wound Journal [Internet]. 2018;15(5):814–821.
Available from: http://dx.doi.org/10.1111/iwj.12932
Shah P., Inturi R., Anne D., Jadhav D., Viswambharan V., Khadilkar R., et al. Wagner’s classification as a tool for treating diabetic foot ulcers: Our observations at a suburban teaching hospital. Cureus [Internet]. 2022 [cited 2023 Jul 26];14(1):e21501.
Available from: http://dx.doi.org/10.7759/cureus.21501
Hobizal K.B., Wukich D.K. Diabetic foot infections: Current concept review. Diabetic Foot & Ankle [Internet]. 2012;3(1):18409.
Available from: http://dx.doi.org/10.3402/dfa.v3i0.18409
Del Core M.A., Ahn J., Lewis R.B. III, Raspovic K.M., Lalli T.A.J., Wukich D.K. The evaluation and treatment of diabetic foot ulcers and diabetic foot infections. Foot & Ankle Orthopaedics [Internet]. 2018;3(3):2473011418788864.
Available from: http://dx.doi.org/10.1177/2473011418788864
Gin A., Dilay L., Karlowsky J.A., Walkty A., Rubinstein E., Zhanel G.G. Piperacillin–tazobactam: A β-lactam/β-lactamase inhibitor combination. Expert Review of Anti-infective Therapy [Internet]. 2007;5(3):365–383.
Available from: http://dx.doi.org/10.1586/14787210.5.3.365
Scholar E. Ceftriaxone. In: xPharm: The Comprehensive Pharmacology Reference. Elsevier; 2007. p. 1–7.
Sekhar M.S., Thomas R.R., Unnikrishnan M.K., Vijayanarayana K., Rodrigues G.S. Impact of diabetic foot ulcer on health-related quality of life: A cross-sectional study. Seminars in Vascular Surgery [Internet]. 2015;28(3–4):165–171.
Available from: https://www.sciencedirect.com/science/article/pii/S0895796715000964
Singh A., Yeola M., Singh N., Damke S. A study on diabetic foot ulcers in Central rural India to formulate empiric antimicrobial therapy. Journal of Family Medicine and Primary Care [Internet]. 2020 [cited 2023 Oct 6];9(8):4216.
Available from: http://dx.doi.org/10.4103/jfmpc.jfmpc_700_20
Gadepalli R., Dhawan B., Sreenivas V., Kapil A., Ammini A.C., Chaudhry R. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care [Internet]. 2006;29(8):1727–1732.
Available from: https://diabetesjournals.org/care/article/29/8/1727
Ghosh P., Valia R. Burden of diabetic foot ulcers in India: Evidence landscape from published literature. Value in Health [Internet]. 2017;20(9):A485.
Available from: http://dx.doi.org/10.1016/j.jval.2017.08.489
Akther J.M., Khan I.A., Shahpurkar V.V., Khanam N., Syed Z.Q. Evaluation of the diabetic foot according to Wagner’s classification in a rural teaching hospital. British Journal of Diabetes & Vascular Disease [Internet]. 2011;11(2):74–79.
Available from: http://dx.doi.org/10.1177/1474651411406372
Polikandrioti M., Vasilopoulos G., Koutelekos I., Panoutsopoulos G., Gerogianni G., Babatsikou F., et al. Quality of life in diabetic foot ulcer: Associated factors and the impact of anxiety/depression and adherence to self-care. International Journal of Lower Extremity Wounds [Internet]. 2020;19(2):165–179.
Available from: https://pubmed.ncbi.nlm.nih.gov/31973632/
Fry W., McCafferty S., Gooday C., Nunney I., Dhatariya K.K. Assessing the effect of piperacillin/tazobactam on hematological parameters in patients admitted with moderate or severe foot infections. Diabetes Therapy [Internet]. 2018;9(1):219–228.
Available from: https://pubmed.ncbi.nlm.nih.gov/29302933/
Zeillemaker A.M., Veldkamp K-E., van Kraaij M.G.J., Hoekstra J.B.L., van Papendrecht A.A.G.M.H., Diepersloot R.J.A. Piperacillin/tazobactam therapy for diabetic foot infection. Foot & Ankle International [Internet]. 1998;19(3):169–172.
Available from: http://dx.doi.org/10.1177/107110079801900311
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.